Related Experiment Videos
Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death
1European Institute for Peptide Research (IFRMP 23), INSERM U519, Rouen, France. van_beek@hotmail.com
Neuroreport
|February 24, 2001
Summary
The complement factor C3a, or complement component 3a, shows neuroprotective effects against NMDA excitotoxicity in neuronal cultures, but only when astrocytes are present. This suggests a novel role for C3a beyond immune responses.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- The complement system, particularly anaphylatoxin C3a (complement component 3a), plays a role in inflammation.
- Neuronal damage following ischemic insults involves excitotoxicity and apoptosis.
Purpose of the Study:
- To investigate the effects of C3a on neuronal survival after ischemic insult.
- To determine if C3a influences apoptotic or excitotoxic neuronal death.
Main Methods:
- Primary murine cortical cell cultures (neurons and astrocytes) were exposed to apoptotic (serum deprivation) and excitotoxic (AMPA/kainate, NMDA) paradigms.
- The effects of purified human C3a on neuronal survival were assessed.
Main Results:
- C3a did not prevent serum deprivation-induced apoptosis or AMPA/kainate excitotoxicity.
- C3a demonstrated dose-dependent neuroprotection against NMDA excitotoxicity in mixed neuron-astrocyte cultures.
- Neuroprotection by C3a was dependent on the presence of astrocytes.
Conclusions:
- C3a exhibits neuroprotective properties against NMDA-induced excitotoxicity, specifically in the presence of astrocytes.
- These findings suggest C3a's involvement in modulating excitotoxicity-mediated neuronal death via astrocyte stimulation.
- The study extends the known functions of C3a beyond its traditional immune roles.